Oncotype Dx Recurrence Score Among BRCA1/2 Germline Mutation Carriers With Hormone Receptors Positive Breast Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.30616
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Treatment Decisions in Estrogen Receptor-Positive Early Breast Cancer Patients With Intermediate Oncotype DX Recurrence Score Results

SpringerPlus
Multidisciplinary
2014English

Oncotype DX Breast Cancer Recurrence Score Resists Inter-Assay Reproducibility With RT2-Profiler Multiplex RT-PCR

Scientific Reports
Multidisciplinary
2019English

The ZNF217 Biomarker Predicts Low- And High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers

Frontiers in Pharmacology
Pharmacology
2019English

Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Body Weight and Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

RASSF1A Polymorphism A133S Is Associated With Early Onset Breast Cancer in BRCA1/2 Mutation Carriers

Cancer Research
Cancer ResearchOncology
2008English

Physical Activity and the Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Sex Differences in Cancer Risk Among Germline P53 Mutation Carriers

British Journal of Cancer
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy